The groundbreaking treatment of this peptide represents a exciting development in the care of the condition. Distinct from existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide529767.affiliatblogger.com/94461439/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment